Skip to main content
Caplight Logo









KeraVet Bio

KeraVet Bio

Private
Winston-Salem, North CarolinaHealthcare & Life Scienceshttps://keravetbio.com/

Last Round

Seed

Apr 3, 2023

Momentum

Top 50%

of companies Caplight tracks

Company Overview

KeraVet Bio is a veterinary biotechnology company that manufactures KeraVet Gel, a prescription keratin-based hydrogel designed to treat wounds and surgical incisions in dogs and cats.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

veterinary wound carekeratin hydrogelveterinary medicinepost-surgical carepet wound managementveterinary pharmaceuticalsincision managementtopical wound gelElizabethan collar alternativee-collar alternativeveterinary biotechpet health productsveterinary suppliesno-lick gel

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KeraVet Bio Comparables

Compare KeraVet Bio with similar companies based on industry and business-model similarity.

KeraVet Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hilltop Bio
80%
Vet Aid
77%
The Hymed Group
77%

KeraVet Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 3, 2023

Key People

Founding team and executive leadership

Luke Burnett

Founder and CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 17, 2026

    Monthly visitors increased 31% MoM.

KeraVet Bio Filings

Explore SEC and related filing metadata, where available.

KeraVet Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about KeraVet Bio's valuation, stock price, and market status.

Is KeraVet Bio a public or private company?

KeraVet Bio is a private company.

What is the current stock price of KeraVet Bio?

KeraVet Bio is a private company with no public stock price. No recent secondary market data is available.

How much is KeraVet Bio worth (valuation)?

Valuation information for KeraVet Bio is not publicly available.

Can I buy KeraVet Bio stock?

KeraVet Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was KeraVet Bio's last funding round?

KeraVet Bio's most recent funding round was Seed on April 3, 2023.

Who are the main investors in KeraVet Bio?

Investor information for KeraVet Bio is not publicly disclosed.

Will KeraVet Bio IPO soon?

No public IPO plans have been announced for KeraVet Bio.

How can I track KeraVet Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor KeraVet Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWinston-Salem, North Carolina
Employee Range11
Year Founded2022
Last FundingApr 3, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?